Pharmacy Partners
A science-led solution for hair loss, confidence, and customer care. Clinically supported and 99% natural. No sulphates, no parabens, no prescription.
The Opportunity
Hair loss is one of the most common yet least discussed concerns faced by both men and women. As a pharmacist, you're often the first point of contact when someone quietly asks, "Do you have something for hair loss?"
At that moment, you have the opportunity to offer more than a product — you can offer reassurance, confidence, and a solution that works. HUSSSH® Hair Recovery Shampoo is a breakthrough in cosmetic hair care, developed to help restore hair strength and thickness without the need for a prescription.
Backed by a clinical study conducted by a Trichologist, the shampoo offers a gentle yet effective alternative to pharmaceutical options that often come with side effects or gender-specific restrictions.
Female Hair Loss
Male Hair Loss
£2.2B — the UK hair care market (Mintel 2025), with pharmacies and salons as the leading point-of-sale channels for clinically-positioned products.
Rigorous clinical evidence from a clinical study conducted by a Trichologist. Download the full report to review methodology, findings, and efficacy data.
Download Full Report (PDF)Almost 50% of people will experience some form of hair loss in their lifetime. Yet very few will feel confident enough to browse the shelves for a solution, especially when they're unsure where to begin. This is where pharmacists can play a vital role. Whether through a casual conversation at the counter or a thoughtful product recommendation, you can guide customers to a solution that is safe, evidence-backed, and easy to use.
HUSSSH® Hair Therapy Shampoo helps your pharmacy become more than just a stop along the way — it becomes part of your customer's confidence journey. With no contraindications, no known side effects, and suitability across genders, it's a universal solution for one of the most personal health concerns people face.
HUSSSH® Hair Therapy Shampoo is classified as a cosmetic and has been approved following a safety study conducted under the Cosmetic Enforcement Regulations. Its timeline for delivering results is similar to that of Finasteride and Minoxidil, and, like these treatments, it requires long-term use to maintain its benefits.
Finasteride 1 mg is a prescription-only treatment for male pattern alopecia. It is not suitable for women due to the risk of significant long-term side effects. When combined with over-the-counter Minoxidil spray, finasteride has been proven effective. It is important to note that some online general practitioners prescribe unlicensed combination therapies ("cocktails") that lack supporting safety data.
HUSSSH® Hair Therapy Shampoo is the prescription-free way to restore lost confidence as a result of hair loss.
Clinical Evidence
The formulation behind HUSSSH® is grounded in clinical data, not marketing hype. Developed over two years, backed by a clinical study conducted by a Trichologist.
People with hair loss enrolled in the clinical study conducted by a Trichologist
Cosmetic Enforcement Regulations safety study completed
Comparable timeline to Finasteride and Minoxidil
Suitable for men and women with no known contraindications
| Feature | HUSSSH® | Finasteride | Minoxidil |
|---|---|---|---|
| Prescription required | No | Yes (men) | OTC available |
| Safe for women | ✓ Yes | ✗ No | Topical only |
| Side effects | None known | Serious (MHRA warning) | Scalp irritation |
| Results timeline | 6–12 weeks | 6–12 months | 3–6 months |
| Natural formula | 99% natural | Synthetic | Synthetic |
Before & After
Documented before-and-after results from HUSSSH® Hair Recovery Shampoo users across our pharmacy and salon partners.
Clinical Evidence
A comprehensive 11-page clinical report commissioned in December 2024, based on trials conducted by a Trichologist in 2022 and 2023.
The report documents methodology, efficacy data, and findings supporting HUSSSH®'s performance as comparable to Finasteride and Minoxidil — without the side effects or prescription requirement.
FAQs
Yes. HUSSSH® Hair Therapy Shampoo is formulated to be gentle and effective across all hair types, including fine, thick, curly, and colour-treated hair. It is free from sulphates, parabens, and artificial fragrances, making it suitable for even the most sensitive scalps.
On average, users begin to see initial results within 6 to 12 weeks of consistent use. Full effects develop over this period. This timeline is comparable to well-known pharmaceutical treatments such as Finasteride and Minoxidil, without the associated side effects.
Absolutely. The formula is specifically designed to be gentle on sensitive scalps. It contains no sulphates, parabens, or artificial fragrances — common irritants found in many commercial shampoos. Many customers with sensitive scalps report improved scalp comfort alongside hair recovery benefits.
HUSSSH® Hair Therapy Shampoo is classified as a cosmetic and has been approved following a safety study under the Cosmetic Enforcement Regulations. Its timeline for delivering results is similar to Finasteride, but it carries no known side effects and is suitable for both men and women — unlike Finasteride, which is not safe for women.
The detailed scientific report is available to registered healthcare professionals. Please contact us at enquiries@hushhealth.co.uk and include your GPhC number to request the full report.
#1 Haircare Trend 2026
According to BeautyMatter and Vogue (April 2026), scalp care has become the defining trend in professional haircare. Consumers are treating their scalp with the same rigour as their skincare routine — seeking clinically credible, ingredient-transparent products from trusted professionals. HUSSSH® is perfectly positioned to meet this demand: a 99% natural, botanically-led formula with documented clinical backing, available exclusively through pharmacies and salons.
Position HUSSSH® as your pharmacy's answer to the scalp care movement.
Contact us today to discuss stocking options, trade pricing, and to request your complimentary clinical report.